「ag」の検索結果
48件：11～15件目を表示
-
March 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
population. 2024. #4:横井則彦，加藤弘明：ドライアイ診療のパラダイムシフト 眼表面の層別診断・層別治療．京府医大誌, 2013 122(8) : 549-57 #5: Nakagawa T, Tokuda Y, Nakano M, Komori Y, Hanada N, Tourtas T, et al. RNA-Seq-based transcriptome analy...
https://www.senju.co.jp/rd/policy/ -
論文投稿実績 | 研究開発活動 | 千寿製薬株式会社
ogy. 2026;283:163-175. 外部リンク Cost‑effectiveness Analysis of Ranibizumab Biosimilar for Neovascular Age‑Related Macular Degeneration and its Subtypes from the Societal and Patient Perspectives in Japa...
https://www.senju.co.jp/rd/thesis/ -
d by ocular surface disorder” *. Recently, the number of DED patients has been increasing due to an aging population, the long-term use of contact lenses, and the widespread use of Visual Display Term...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
Milestones in Our History | About Senju | SENJU Pharmaceutical
ffice relocated to Higashi-ku, Osaka. Manufacturing plant relocated to Ashiya-shi, Hyogo. 1951 June Agreement for the sole distribution of Senju Products through Takeda Pharmaceutical Company Limited....
https://www.senju.co.jp/english/about/history.html